|Phone||+32 (0)16 28 41 28|
Quest for Growth focuses on European technology-based growth companies covering such sectors as life sciences, information technology, software, semiconductors, telecommunications, electronics, and new materials, as well as special situations in other growth sectors.
Quest for Growth invests in growth companies with the objective of converting capital gains into tax-free income through the Privak structure. The largest part of the portfolio is invested in growth companies listed on European stock exchanges (Euronext, London Stock Exchange, Deutsche BÃ¶rse etc) and other regulated markets. The remainder will be invested in unquoted companies working towards an introduction to a stock exchange or trade sale within 36 months. Quest for Growth rarely invests in start-ups or early stage companies.
Within the category of unquoted companies, up to 15 % of the assets can be invested in venture or private equity funds having an investment policy compatible with that of Quest for Growth.
As of December 31, 2008, funds under management amounted to â‚¬ 67 million. Quest for Growth has been listed on Euronext Brussels since September 23rd 1998.
|Kiadis Pharma||11/12||Venture Round||€10M||4|
|Active Circle||9/08||Series B||$11M||3|
|TcLand Expression||12/07||Series A||€8.2M||4|
|MAPPER Lithography||5/07||Series B||$510k||2|
|Welcome Real-time||5/05||Venture Round||$620k||2|